Molecular studies of matrix metalloproteinases and tissue inhibitors of metalloproteinases in equine joints

Veterinary Journal

Volumn 157, Issue 3, 1999, Pages 336-338

  Clegg, P D ^a   Radford, A D ^a   Carter, S D ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Horse; Joint disease; MMP; mRNA; PCR; TIMP

Indexed keywords

EQUIDAE; EQUUS CABALLUS;

MESSENGER RNA; METALLOPROTEINASE; PRIMER DNA; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL; ANIMAL DISEASE; ARTICLE; ARTICULAR CARTILAGE; CHEMISTRY; CYTOLOGY; DNA SEQUENCE; ENZYMOLOGY; FIBROBLAST; GENETICS; HORSE; JOINT; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; MONOCYTE; NEUTROPHIL; NUCLEOTIDE SEQUENCE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNOVIUM;

ANIMALS; BASE SEQUENCE; CARTILAGE, ARTICULAR; CLONING, MOLECULAR; DNA PRIMERS; FIBROBLASTS; HORSES; JOINTS; METALLOENDOPEPTIDASES; MOLECULAR SEQUENCE DATA; MONOCYTES; NEUTROPHILS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; SYNOVIAL MEMBRANE; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0033129661     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1053/tvjl.1998.0328     Document Type: Article

References (14)

1. BIRKEDAL-HANSEN, H., MOORE, W.G.I., BODDEN, M.K., WINDSOR, L.J., BIRKEDAL-HANSEN, B., DECARLO, A. & ENGLER, J.A. (1993). Matrix metalloproteinases; a review. Critical Reviews in Oral Biology and Medicine 4, 197-250.
2. CARON, J.P., TARDIF, G., MARTEL-PELLETIER, J., DIBATTISTA, J.A., GENG, C. & PELLETIER, J-P. (1996). Modulation of matrix metalloprotease 13 (collagenase 3) gene expression by interleukin 1 and corticosteroids. American Journal of Veterinary Research 57, 1631-4.
3. CAWSTON, T.E. (1995). Proteinases and inhibitors. British Medical Bulletin 51, 385-401.
4. CLEGG, P.D., BURKE, R.M., COUGHLAN, A.R., RIGGS, C.M. & CARTER, S.D. (1997a). Characterisation of equine matrix metalloproteinase 2 & 9 and identification of the cellular sources of these enzymes in joints. Equine Veterinary Journal 29, 335-42.
5. CLEGG, P.D., COUGHLAN, A.R., RIGGS, C.M. & CARTER, S.D. (1997b). Matrix metalloproteinase 2 & 9 in equine synovial fluid. Equine Veterinary Journal 29, 343-8.
6. CLEGG, P.D., COUGHLAN, A.R., & CARTER, S.D. (1998). Equine TIMP-1 & 2: identification, characterisation and cellular sources in joint disease. Equine Veterinary Journal 30, 416-23.
7. DEVARAJAN, P., JOHNSTON, J.J., GINSBERG, S.S., VAN WART, H.E. & BERLINER, N. (1992). Structure and expression of neutrophil gelatinase cDNA. Journal of Biological and Chemistry 267, 25228-32.
8. DEVERAUX, J., HAEBERLI, P. & SMITHIES, O. (1984). A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Research 12, 387-95.
9. FOSANG, A.J., LAST, K.N. & MACIEWICZ, R.N. (1996). Aggrecan is degraded by matrix metalloproteinases in human arthritis. Journal of Clinical Investigation 98, 2292-9.
10. MCILWRAITH, C.W. & VACHON, A. (1988). Review of pathogenesis and treatment of degenerative joint disease. Equine Veterinary Journal 6 (Suppl.) 3-11.
11. RICHARDSON, D.W. & DODGE, G.R. (1996). Effects of tumour necrosis factor-alpha, interleukin-1-Beta and dexamethasone on the matrix metabolism of cultured equine chondrocytes. Proc. 42nd annual meeting, Orthopedic Research Society 42, 126.
12. SPIERS, S., MAY, S.A., BENNETT, D. & EDWARDS, G.B. (1994). Cellular sources of proteolytic-enzymes in equine joints. Equine Veterinary Journal 26, 43-7.
13. TRIEBEL, S., BLASER, J., GOTE, T., PELZ, G., SCHUREN, E., SCHMITT, M. & TSCHESCHE, H. (1995). Evidence for the tissue inhibitor of metalloproteinase-1 (TIMP-1) in human polymorphonuclear leukocytes. European Journal of Biochemistry 231, 714-9.
14. WOESSNER, J.F. (1991). Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB Journal 5, 2145-54.